Abstract
Purpose
To improve the understanding of divergence paralysis by identifying its clinical characteristics.
Methods
We performed a retrospective chart review analysis of patients diagnosed with divergence paralysis that were followed up for at least 6 months. Clinical features, including disease onset, course, neurological examinations, and imaging studies were evaluated.
Results
Fifteen patients were included in the present study and the average age was 55.6 years. Thirteen patients had an acute onset and 2 had an insidious onset. The initial distance deviation ranged from 4 to 14 prism diopters (PD) of esotropia (mean, 8 PD esotropia) and near deviation ranged from 6 PD exophoria to 10 PD esophoria (mean, 1.2 PD esophoria). None of the patients developed additional neurological disorders associated with divergence paralysis during the follow-up period. Eleven of 13 patients with primary divergence paralysis continued to depend on the prism glasses with the same diopters. In the 2 patients with secondary divergence paralysis, distant diplopia disappeared as the underlying disease improved.
Conclusions
In our study, the majority of divergence paralysis was not associated with neurological diseases and the patients had an acute onset. Primary divergence paralysis lasted for an extended period. However, secondary divergence paralysis was resolved quickly as the underlying disease improved.
References
1. Bielschowsky A. Lectures on motor anomalies of the eyes: III. Paralysis of conjugate movements of the eyes. Arch Ophthalmol. 1935; 13:580–5.
2. von Noorden GK, Campos EC. Binocular vision and ocular motility: theory and management of strabismus. 6th ed.St. Louis: Mosby;2002. p. 505–6.
3. Jacobson DM. Divergence insufficiency revisited: natural history of idiopathic cases and neurologic associations. Arch Ophthalmol. 2000; 118:1237–41.
4. Wiggins RE Jr, Baumgartner S. Diagnosis and management of divergence weakness in adults. Ophthalmology. 1999; 106:1353–6.
5. Sargent JC. Nuclear and infranuclear ocular motility disorders. Miller NR, Newman NJ, editors. Walsh and Hoyt's Clinical Neuro-Ophthalmology. 6th ed.Baltimore: Williams & Wilkins;2005. 1:chap. 20.
6. Krohel GB, Tobin DR, Hartnett ME, Barrows NA. Divergence paralysis. Am J Ophthalmol. 1982; 94:506–10.
8. Lim L, Rosenbaum AL, Demer JL. Saccadic velocity analysis in patients with divergence paralysis. J Pediatr Ophthalmol Strabismus. 1995; 32:76–81.
11. Bakker SL, Gan IM. Temporary divergence paralysis in viral meningitis. J Neuroophthalmol. 2008; 28:111–3.
12. Arai M, Fujii S. Divergence paralysis associated with the ingestion of diazepam. J Neurol. 1990; 237:45–6.
13. Kirkham TH, Bird AC, Sanders MD. Divergence paralysis with raised intracranial pressure. An electro-oculographic study. Br J Ophthalmol. 1972; 56:776–82.
14. CHAMLIN M, DAVIDOFF LM. Divergence paralysis with increased intracranial pressure. J Neurosurg. 1950; 7:539–43.
15. Pinchoff BS, Slavin ML, Rosenstein D, Hyman R. Divergence paralysis as the initial sign in the Miller Fisher syndrome. Am J Ophthalmol. 1986; 101:741–2.
16. Rosenbaum AL, Kushner BJ, Kirschen D. Vertical rectus muscle transposition and botulinum toxin (Oculinum) to medial rectus for abducens palsy. Arch Ophthalmol. 1989; 107:820–3.